Bob Peterson, VP of Prod. Development & Reg. Aff's at NephroGenex, Inc. (NRX), bought 2,000 shares at $4.20 ($8K) on 2014-11-25, disclosed to the SEC on 2014-11-25.
Open-market purchase of $8k NRX by VP of Prod. Development & Reg. Aff's. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.